Chronic Kidney Disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: Receiving oral capsule of Vitamin E. Intervention 2: Control group: Receiving oral capsule of placebo.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Hemodialysis Patients 18-70 years old Shiraz University of Medical Sciences HD center Maintenance HD at least for 3 months
Exclusion criteria
Exclusion criteria: Smoking and alcohol consumer Anti-oxidant supplements use Liver or Heart Failure Diabetes mellitus Obstructive uropathy Endocrine cancers Hemoglobine <9 mg/dL Coronary vessels disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure (systolic and diastolic). Timepoint: Before the intervention, the beginning of the intervention (the first day), the end of each week after the intervention and the end of the intervention (the end of the eighth week). Method of measurement: Measure blood pressure using sphygmomonometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of vitamin E on serum creatinine. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Jaffe method - Autoanalyzer.;Effect of vitamin E on hemoglobine. Timepoint: Before and after 8 weeks of intervention. Method of measurement: cyanmethemoglobin method (CM)- Spectrophotometric method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJamshid Roozbeh
Shiraz University of Medical Sciences
Outcome results
None listed